Alan Brooks
Corporate Officer/Principal presso METAGENOMI, INC.
Profilo
Alan Brooks is currently working as the Senior Vice President-Preclinical at Metagenomi, Inc. He previously worked as the Vice President-Preclinical & Director-Preclinical at Metagenomi Technologies LLC from 2019 to 2023.
Before that, he was a Principal Scientist at Casebia Therapeutics LLC from 2017 to 2019.
Dr. Brooks holds a doctorate degree from the University of Warwick and an undergraduate degree from the University of Leicester.
Posizioni attive di Alan Brooks
| Società | Posizione | Inizio |
|---|---|---|
| METAGENOMI, INC. | Corporate Officer/Principal | 01/11/2019 |
Precedenti posizioni note di Alan Brooks
| Società | Posizione | Fine |
|---|---|---|
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Corporate Officer/Principal | 01/08/2019 |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Formazione di Alan Brooks
| University of Warwick | Doctorate Degree |
| University of Leicester | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| METAGENOMI, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Health Technology |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
- Borsa valori
- Insiders
- Alan Brooks
